Symberix is developing microbiome-targeted, small-molecule drugs to treat serious lower gastrointestinal (GI) diseases as well as mitigate the lower GI side effects associated with various cancer, pain and immunosuppressive therapies.
Company Location
4819 Emperor Blvd., Suite 400
Durham
NC
27703
County
Region
Company Details
Company type
Year founded
2012
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products under development
SBX-101, SBX-201, SBX-301